FDA Fast Track Designation Sends Biotech Soaring Mid-Week
February 12 2025 - 4:10PM
AllPennyStocks.com
A California-based biotech found some serious
success on Wednesday after the company received FDA fast track
designation for Troculeucel, used for the treatment of
moderate...
To read the full story on AllPennyStocks.com, click
here.
NKGen Biotech (NASDAQ:NKGN)
Historical Stock Chart
From May 2025 to Jun 2025
NKGen Biotech (NASDAQ:NKGN)
Historical Stock Chart
From Jun 2024 to Jun 2025